A population-based registry study of 844,696 patients demonstrates that pure mucinous carcinoma exhibits significantly superior breast cancer-specific survival compared with mixed mucinous carcinoma and invasive ductal carcinoma.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.